GlassScriptPhysician profile
Amro Abbas Taha
NPI 1023771128
$1,047.49
in general payments reported to CMS, 2019-2025
10 companies · $767 in 2025
The $767 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $280 · 2025: $767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $948 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $948.49 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endotronix, INC. | $222.81 | 2025 | Cordella Pulomonary Artery Pressure Sensor, Cordella Pulmonary Artery Pressure Sensor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $205.15 | 2024-2025 | Lifevest |
| Heartflow, INC. | $151.85 | 2025 | |
| Boston Scientific Corporation | $130.34 | 2025 | Avvigo Guidance System |
| Stryker Corporation | $121.68 | 2025 | Flowtriever |
| Novartis Pharmaceuticals Corporation | $100.07 | 2024-2025 | |
| Teleflex LLC | $37.66 | 2024 | Manta |
| Pfizer INC. | $35.00 | 2025 | |
| Cvrx, INC. | $22.59 | 2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $20.34 | 2024 | Wainua |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amro Taha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.